Page last updated: 2024-10-27

gentamicin and Gram-Negative Bacterial Infections

gentamicin has been researched along with Gram-Negative Bacterial Infections in 130 studies

Gentamicins: A complex of closely related aminoglycosides obtained from MICROMONOSPORA purpurea and related species. They are broad-spectrum antibiotics, but may cause ear and kidney damage. They act to inhibit PROTEIN BIOSYNTHESIS.

Gram-Negative Bacterial Infections: Infections caused by bacteria that show up as pink (negative) when treated by the gram-staining method.

Research Excerpts

ExcerptRelevanceReference
"To evaluate the impact of an antimicrobial stewardship (AMS) intervention, involving introduction of new guidelines on the treatment of febrile neutropenia (FN), on improving the use of gentamicin in paediatric oncology patients."9.27Antimicrobial stewardship in paediatric oncology: Impact on optimising gentamicin use in febrile neutropenia. ( Bialkowski, S; Clark, J; Consuelo Llanos Paez, C; Hennig, S; Lawson, R; Natanek, D; Staatz, CE, 2018)
"In a prospective multicentre open trial, hospitalised adult patients with acute lower respiratory tract infections, mainly pneumonia or bronchitis, were randomised to receive either isepamicin 8 or 15 mg/kg once daily depending on the severity of the infection or amikacin 7."9.08Comparison of the efficacy and safety of isepamicin and amikacin in the treatment of acute lower respiratory tract infections caused by gram-negative organisms. ( Covi, M; Velluti, G, 1995)
"The efficacy of aztreonam in combination with vancomycin was compared with that of gentamicin plus piperacillin as empirical antibiotic treatment for fever in 61 neutropenic patients."9.07Aztreonam plus vancomycin versus gentamicin plus piperacillin as empirical therapy for the treatment of fever in neutropenic patients: a randomised controlled study. ( Kelsey, SM; Newland, AC; Shaw, E, 1992)
"Because of the rapid emergence of resistance to gentamicin and tobramycin among isolates of aerobic and facultative gram-negative bacteria at our university hospital, we designed a prospective study to track aminoglycoside resistance, bacteremic episodes, and bacteremia-associated deaths before and after the institution of amikacin as the sole formulary aminoglycoside."7.68Alterations in the microbial flora and in the incidence of bacteremia at a university hospital after adoption of amikacin as the sole formulary aminoglycoside. ( Conrad, SA; King, JW; Todd, JR; White, MC, 1992)
"To evaluate the impact of an antimicrobial stewardship (AMS) intervention, involving introduction of new guidelines on the treatment of febrile neutropenia (FN), on improving the use of gentamicin in paediatric oncology patients."5.27Antimicrobial stewardship in paediatric oncology: Impact on optimising gentamicin use in febrile neutropenia. ( Bialkowski, S; Clark, J; Consuelo Llanos Paez, C; Hennig, S; Lawson, R; Natanek, D; Staatz, CE, 2018)
"In a prospective multicentre open trial, hospitalised adult patients with acute lower respiratory tract infections, mainly pneumonia or bronchitis, were randomised to receive either isepamicin 8 or 15 mg/kg once daily depending on the severity of the infection or amikacin 7."5.08Comparison of the efficacy and safety of isepamicin and amikacin in the treatment of acute lower respiratory tract infections caused by gram-negative organisms. ( Covi, M; Velluti, G, 1995)
"Fifty children aged 3 months--16 y with Gram-negative bacterial infections, were evaluated in this open randomized study; 26 received gentamicin 4."5.08Gentamicin once-daily versus thrice-daily in children. ( Elhanan, K; Raz, R; Siplovich, L, 1995)
"The efficacy of aztreonam in combination with vancomycin was compared with that of gentamicin plus piperacillin as empirical antibiotic treatment for fever in 61 neutropenic patients."5.07Aztreonam plus vancomycin versus gentamicin plus piperacillin as empirical therapy for the treatment of fever in neutropenic patients: a randomised controlled study. ( Kelsey, SM; Newland, AC; Shaw, E, 1992)
" Gentamicin has comparable efficacy to mupirocin for peritonitis and gram-positive exit-site infection."4.98Comparison of topical mupirocin and gentamicin in the prevention of peritoneal dialysis-related infections: A systematic review and meta-analysis. ( Cheng, SP; Hsu, YC; Liu, CL; Tsai, CC; Wu, CJ; Yang, PS, 2018)
"The aim of this study was to describe the safety profile and pharmacokinetic/pharmacodynamic parameters in end-stage renal disease patients who received gentamicin as empirical treatment in catheter-related bacteremia when they showed infection signs, regardless of the timing of the next HD."3.91Gentamicin as Empirical Treatment in Hemodialysis Patients: Safety, Pharmacokinetics, and Pharmacodynamics. ( Camacho-Martínez, P; Gil-Navarro, MV; Gil-Sacaluga, L; Guisado-Gil, AB; Herrera-Hidalgo, L; Lepe-Jiménez, JA; Molina, J; Santos-Rubio, MD, 2019)
" The majority of gram-negative bacterial infections were multidrug resistant, but 17 of the 20 gram-negative bacteria were sensitive to meropenem."3.81Bacteria causing ventriculoperitoneal shunt infections in a Kenyan population. ( Albright, AL; Ferson, S; Ochieng', N; Okechi, H, 2015)
"This prospective, comparative study was designed to estimate the volume of distribution (Vd) and elimination rate constant (K(e)) of gentamicin and to determine the clinical factors affecting the pharmacokinetics of gentamicin in different stages of sepsis."3.70Factors affecting gentamicin pharmacokinetics in septic patients. ( Kong, CW; Lee, TY; Lin, BS; Tang, GJ; Tang, JJ, 1999)
"Almost 30 years after its introduction, gentamicin continues to play a key role in the treatment of gram negative sepsis."3.69Gentamicin once a day. ( MacConnachie, AM, 1996)
"Because of the rapid emergence of resistance to gentamicin and tobramycin among isolates of aerobic and facultative gram-negative bacteria at our university hospital, we designed a prospective study to track aminoglycoside resistance, bacteremic episodes, and bacteremia-associated deaths before and after the institution of amikacin as the sole formulary aminoglycoside."3.68Alterations in the microbial flora and in the incidence of bacteremia at a university hospital after adoption of amikacin as the sole formulary aminoglycoside. ( Conrad, SA; King, JW; Todd, JR; White, MC, 1992)
" Doctors feared inducing toxicity in patients, but limited the dose rather than altering the dosing interval according to renal function."2.80Does the availability of therapeutic drug monitoring, computerised dose recommendation and prescribing decision support services promote compliance with national gentamicin prescribing guidelines? ( Baysari, M; Day, RO; Diasinos, N; Kumar, S, 2015)
" Single daily dosing with GM, regardless of the total daily dose, produced less nephrotoxicity than multiple dosing."2.74A prospective comparative study of gentamicin- and amikacin-induced nephrotoxicity in patients with normal baseline renal function. ( Sweileh, WM, 2009)
"Gentamicin use was a significant predictor of lower peritonitis rates (relative risk, 0."2.71Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients. ( Bender, F; Bernardini, J; Florio, T; Fried, L; Palmmontalbano, L; Piraino, B; Sloand, J, 2005)
"The results of our study indicated that once daily dosing of gentamycin was superior to multiple daily dosing in treating the lower respiratory tract infection in the study population."2.71Evaluation of target concentration intervention strategy of gentamicin therapy in a malnourished patient population of south India. ( Karthikeyan, VP; Rajendran, SD; Rao, YM, 2005)
"Netilmicin also was more effective than gentamicin in eradicating infections (p = 0."2.70Treatment of acute bacterial conjunctivitis with topical netilmicin. ( Aragona, P; Blanco, AR; Di, BA; Milazzo, G; Papa, V; Santocono, M; Scuderi, AC; Zola, P, 2002)
" A once daily dosing regimen of gentamicin is more effective and less ototoxic than a thrice daily regimen."2.68Intravenous administration of gentamicin once daily versus thrice daily in adults. ( Adawi, M; Raz, R; Romano, S, 1995)
" Therefore, in adult patients with a wide range of infections requiring aminoglycoside therapy, once-daily dosing with isepamicin is as effective as twice- daily dosing with amikacin."2.68Overview of the efficacy of isepamicin in the adult core clinical trial programme. ( Carbon, C, 1995)
" The proportion of patients experiencing at least one adverse event was 11%, 25% and 9% for isepamicin once daily, isepamicin twice daily and amikacin, respectively."2.68Evaluation of the efficacy and safety of isepamicin compared with amikacin in the treatment of nosocomial pneumonia and septicaemia. ( Beaucaire, G, 1995)
" Adverse events were reported in 12% of patients in the isepamicin group and 6% in the amikacin group."2.68Comparison of the efficacy and safety of isepamicin and amikacin in the treatment of skin and skin structure infections. ( Esparza-Ahumada, S; Morfin-Otero, R; Rodriguez-Noriega, E, 1995)
" Fourteen per cent of isepamicin and 11% of amikacin patients experienced adverse events."2.68The efficacy and safety of isepamicin and ceftazidime compared with amikacin and ceftazidime in acute lower respiratory tract infection. ( Colardyn, F, 1995)
"Isepamicin is a new aminoglycoside with in-vitro activity superior to amikacin."2.68Isepamicin once daily plus ceftriaxone versus amikacin plus ceftriaxone in febrile neutropenic patients. ( Blaise, D; Cordonnier, C; Espinouse, D; Herbrecht, R; Leblond, V; Minozzi, C; Sadoun, A; Sauvage, C, 1995)
"The cause of bacterial meningitis is changing and first-line antimicrobial therapy and adjuvant therapies are evaluated."2.52Improving the outcome of bacterial meningitis in newborn infants in Africa: reflections on recent progress. ( Dube, Q; Molyneux, EM; Newberry, L, 2015)
" Conversely paediatric studies have shown lower rates and extended interval dosing may have reduced toxicity further."2.50Aminoglycoside toxicity in neonates: something to worry about? ( Heath, PT; Kent, A; Sharland, M; Turner, MA, 2014)
" The standard daily dosing (SDD) in infants and children is twice or three times daily depending on age."2.41Once daily dosing of gentamicin in infants and children. ( Miron, D, 2001)
"Gentamicin is an aminoglycoside antibiotic used in the treatment of gram-negative infections."2.38A review of gentamicin use in neonates. ( Fisk, KL, 1993)
"Ampicillin resistance was found in 113 cases (95%), cefotaxime 104 (87%), gentamicin 101 (85%), AmpGen 101 (85%), piperacillin-tazobactam 47 (39%), amikacin 10 (8."1.62Prevalence and risk factors for antimicrobial resistance among newborns with gram-negative sepsis. ( Abayneh, M; Akeju, O; Ambachew, R; Bekele, D; Carvalho, MJ; Chan, GJ; Gebreyohannes, Z; Goddard, FGB; Metaferia, G; Milton, R; Odumade, OA; Sands, K; Solomon, S; Thomson, K; Van Wickle, K; Walsh, TR, 2021)
"Septicemia is one of the most fulminant forms, but diagnosis of C."1.51Infective endocarditis caused by Capnocytophaga canimorsus; a case report. ( Imanaka, K; Kawamura, T; Kodana, M; Maesaki, S; Matsuoka, T; Nishida, Y; Ohgane, K; Ohno, H; Oka, H; Sakai, J; Sekine, S; Yamamoto, K, 2019)
" In conclusion, gentamicin is safe and has similar outcomes to alternative Gram-negative antimicrobial regimens for empirical coverage in severe CAP patients admitted to the ICU."1.48Is gentamicin safe and effective for severe community-acquired pneumonia? An 8-year retrospective cohort study. ( Brereton, CJ; Browning, S; Davis, JS; Dunn, E; Ferguson, JK; Lennon, D, 2018)
"However, coinfection is rarely described and its occurrence frequency is unknown."1.48Mixed pneumonic plague and nosocomial MDR-bacterial infection of lung: a rare case report. ( Andrianaivoarimanana, V; Bertherat, E; Rajaonarison, R; Rajerison, M; Rakotondramaro, T; Rogier, C, 2018)
"In liver transplant (LT) recipients, surgical site infection (SSI) represents an important cause of morbidity and mortality."1.43Impact of a Multimodal Approach in Prevention of Surgical Site Infection in Hepatic Transplant Recipients. ( Abelleira, M; Castelli, J; Etlin, A; Gerona, S; González, LS; Grecco, G; Harguindeguy, M; Iglesias, C; Leites, A; López, M; Medina, JC; Menéndez, J; Prieto, J; Rando, K; Scalone, P; Valverde, M, 2016)
"Yet, isepamicin was active against 29."1.38Antimicrobial susceptibility of non-fermenting Gram-negative isolates to isepamicin in a region with high antibiotic resistance. ( Falagas, ME; Georgantzi, GG; Kofteridis, DP; Maraki, S; Samonis, G; Vouloumanou, EK, 2012)
"Isepamicin is a newly introduced aminoglycoside in Taiwan."1.34In vitro activity of isepamicin and other aminoglycosides against clinical isolates of Gram-negative bacteria causing nosocomial bloodstream infections. ( Chang, SC; Feng, NH; Hsueh, PR; Tsai, TY; Wang, JT, 2007)
" Standard treatment included a two-stage procedure involving externalization of the ventricular catheter in combination with intraventricular and systemic administration of antibiotic medication followed by shunt replacement."1.34Treatment of cerebrospinal fluid shunt infections in children using systemic and intraventricular antibiotic therapy in combination with externalization of the ventricular catheter: efficacy in 34 consecutively treated infections. ( Arnell, K; Enblad, P; Sjölin, J; Wester, T, 2007)
" The optimized population model allowed us to simulate gentamicin serum levels and their variability, in this kind of patient, when extended-interval dosage administration regimens were implemented."1.32Pharmacokinetic basis for the use of extended interval dosage regimens of gentamicin in neonates. ( Calvo, MV; Carbajosa, MT; Domínguez-Gil, A; Lanao, JM; Martín-Suárez, A; Mesa, JA; Miguelez, F, 2004)
"Severe thrombocytopenia is a life-threatening condition."1.32Cardiobacterium hominis endocarditis associated with very severe thrombocytopenia and platelet autoantibodies. ( Arnold, DM; Christjanson, L; Smaill, F; Walker, I; Warkentin, TE, 2004)
" All of the pharmacokinetic parameters of interest were determined using Bayesian pharmacokinetic procedures and only two plasma gentamicin concentrations."1.32Bayesian pharmacokinetics of gentamicin in a haemodialysis population. ( Ariano, RE; Vercaigne, LM; Zacharias, JM, 2004)
"Respiratory tract infections were the commonest source of infection, and were associated with ventilator therapy rather than the underlying medical condition."1.30Survey of aerobic bacterial infections in paediatric surgical intensive care unit patients. ( Tan, CE; Tan, ML; Yap, KP, 1998)
"Cefazolin was equivalent to vancomycin for empiric treatment of clinically significant infections in a population with a low rate of methicillin-resistant Staphylococcus aureus infection."1.30Cefazolin in chronic hemodialysis patients: a safe, effective alternative to vancomycin. ( Feintzeig, ID; Fogel, MA; Gavin, JP; Hunt, WA; Kim, RC; Nussbaum, PB, 1998)
" Specific physiologic criteria of sepsis may be used to identify critically ill patients who will most likely benefit from aggressive initial aminoglycoside dosing when these drugs are used to treat gram-negative infections."1.30Aminoglycoside levels in critically ill surgical patients: the implications of physiologic criteria of sepsis. ( Asensio, JA; Belzberg, H; Berne, TV; Cornwell, EE; Demetriades, D; Henriques, G; Kern, JW, 1997)
"The performance of dosage guidelines for starting gentamicin therapy was evaluated prospectively in 50 patients with suspected or proven Gram-negative septicaemia and the results were compared with results from similar group of 50 patients for whom the guidelines were not followed."1.29Antimicrobial practice. Development of guidelines for gentamicin dosing. ( Alcock, S; Duncan, N; Jodrell, D; Silverstein, B; Thomson, AH, 1996)
"Fifty-four surgical/trauma patients who had Gram-negative sepsis."1.29Physiologic response of stress and aminoglycoside clearance in critically ill patients. ( Cerra, FB; Miller, TQ; Shikuma, LR; Tholl, DA; Woodward, JM; Zaske, DE, 1993)
" Given the disparity among various in vitro susceptibility methods, this study incorporated a unique pharmacodynamic model to more accurately characterize the bacterial time-kill curves and mutation rates of four clinical isolates of S."1.29Stenotrophomonas maltophilia: emergence of multidrug-resistant strains during therapy and in an in vitro pharmacodynamic chamber model. ( Anderson, DE; Anderson, JD; Campbell, DM; Carroll, KC; Garrison, MW; Hollis, RJ; Malone, CL; Pfaller, MA, 1996)
"This study was designed to develop a population-specific dosing nomogram for gentamicin in medical intensive care unit (MICU) patients using the population pharmacokinetic program nonparametric expectation maximization (NPEM)."1.29Population pharmacokinetics: development of a medical intensive care unit-specific gentamicin dosing nomogram. ( Kisor, DF; Watling, SM, 1993)
"173 nontrachomatous conjunctivitis studied at the I."1.28[Tropical conjunctivitis: infectious etiology and validation of its clinical features]. ( Castan, R; Guillemot de Liniers, F; Huguet, P; Peyramaure, F; Resnikoff, S, 1991)
"Gentamicin was the most active antibiotic with ED50 values of 0."1.26The in-vivo antibacterial activity of ceftazidime (Gr 20263)--a comparison with other new beta-lactam antibiotics and gentamicin. ( Acred, P; Ryan, DM; Sowa, MA; Watts, CM, 1981)

Research

Studies (130)

TimeframeStudies, this research(%)All Research%
pre-19902 (1.54)18.7374
1990's56 (43.08)18.2507
2000's37 (28.46)29.6817
2010's32 (24.62)24.3611
2020's3 (2.31)2.80

Authors

AuthorsStudies
Højgaard, SMM1
Rezahosseini, O1
Knudsen, JD1
Fuglebjerg, NJU1
Skov, M1
Nielsen, SD1
Harboe, ZB1
Sakai, J1
Imanaka, K1
Kodana, M1
Ohgane, K1
Sekine, S1
Yamamoto, K1
Nishida, Y1
Kawamura, T1
Matsuoka, T1
Maesaki, S1
Oka, H1
Ohno, H1
Vidal-Veuthey, B1
Jara, R1
Santander, K1
Mella, A1
Ruiz, S1
Collado, L1
Solomon, S1
Akeju, O1
Odumade, OA1
Ambachew, R1
Gebreyohannes, Z1
Van Wickle, K1
Abayneh, M1
Metaferia, G1
Carvalho, MJ1
Thomson, K1
Sands, K1
Walsh, TR1
Milton, R1
Goddard, FGB1
Bekele, D1
Chan, GJ1
Tsai, CC1
Yang, PS1
Liu, CL1
Wu, CJ2
Hsu, YC1
Cheng, SP1
Marsicek, SM1
Berman, D1
Hennig, S1
Staatz, CE1
Natanek, D1
Bialkowski, S1
Consuelo Llanos Paez, C1
Lawson, R1
Clark, J1
Brereton, CJ1
Lennon, D1
Browning, S1
Dunn, E1
Ferguson, JK1
Davis, JS1
Andrianaivoarimanana, V1
Bertherat, E1
Rajaonarison, R1
Rakotondramaro, T1
Rogier, C1
Rajerison, M1
Walker, O1
Babb, C1
Karampatsas, K1
Richards, J1
Kennea, N1
Guisado-Gil, AB1
Herrera-Hidalgo, L1
Santos-Rubio, MD1
Gil-Sacaluga, L1
Molina, J1
Lepe-Jiménez, JA1
Camacho-Martínez, P1
Gil-Navarro, MV1
Padilla-Orozco, M1
Mendoza-Flores, L1
Herrera-Alonso, A1
Garza González, E1
Gutiérrez Ferman, JL1
Rodríguez-López, JM1
Bocanegra-Ibarias, P1
Camacho-Ortiz, A1
Manoraj, A1
Thevanesam, V1
Bandara, BMR1
Ekanayake, A1
Liyanapathirana, V1
Weichman, KE1
Levine, SM1
Wilson, SC1
Choi, M1
Karp, NS1
Chen, PL1
Chen, CS1
Tsai, PJ1
Tang, HJ1
Ko, WC1
Kent, A1
Turner, MA1
Sharland, M1
Heath, PT1
Ducoulombier, V1
Budzik, JF1
Dehecq, E1
Baclet, N1
Houvenagel, E1
Diasinos, N1
Baysari, M1
Kumar, S1
Day, RO1
Ochieng', N1
Okechi, H1
Ferson, S1
Albright, AL1
Molyneux, EM1
Dube, Q1
Newberry, L1
Prior, FH1
O'Hara, K1
Whyte, IM1
Prieto, J1
Medina, JC1
López, M1
Rando, K1
Iglesias, C1
Harguindeguy, M1
Leites, A1
Etlin, A1
Menéndez, J1
Valverde, M1
Scalone, P1
Castelli, J1
Grecco, G1
Abelleira, M1
González, LS1
Gerona, S1
Ereshefsky, BJ1
Al-Hasan, MN1
Gokun, Y1
Martin, CA1
Vecten, M1
Martel, H1
Casalta, JP1
Hubert, S1
Lepidi, H1
Habib, G1
Raoult, D1
Gouriet, F1
Le Meur, A1
Albert, JD1
Gautier, P1
Ropars, M1
Perdriger, A1
Gando, N1
Minet, J1
Cormier, M1
Bonnaure-Mallet, M1
Jolivet-Gougeon, A1
Nanayakkara, GM1
Pethiyagoda, P1
Jayasinghe, PN1
Premachandra, U1
Szeto, CC1
Kwan, BC1
Chow, KM1
Law, MC1
Pang, WF1
Chung, KY1
Leung, CB1
Li, PK1
Sweileh, WM1
Acred, P1
Ryan, DM1
Sowa, MA1
Watts, CM1
Wardle, JK1
Selkon, JB1
Ingham, HR1
Smith, A1
Saiman, L1
Zhou, J1
Della-Latta, P1
Jia, H1
Graham, PL1
Conde Rivera, O1
Santos Nores, J1
Borrajo Prol, M1
Pérez Melón, C1
Gupta, D1
Green, J1
Franco-Paredes, C1
Lerakis, S1
Tängdén, T1
Enblad, P2
Ullberg, M1
Sjölin, J2
Falagas, ME2
Karageorgopoulos, DE1
Georgantzi, GG2
Sun, C1
Wang, R1
Rafailidis, PI1
Turnidge, JD1
Waterston, JA1
Samonis, G1
Maraki, S1
Vouloumanou, EK1
Kofteridis, DP1
Shah, SS1
Ohlsson, A2
Shah, VS1
Tsai, SF1
Chen, CH1
Shu, KH1
Wu, MJ1
Ogbolu, DO1
Terry-Alli, OA1
Daini, OA1
Olabiyi, FA1
Igharo, EA1
Poi, MJ1
Pisimisis, G1
Barshes, NR1
Darouiche, RO1
Lin, PH1
Kougias, P1
Bechara, CF1
Toltzis, P1
Dul, MJ1
Hoyen, C1
Salvator, A1
Walsh, M1
Zetts, L1
Toltzis, H1
Amaya, RA1
Edwards, MS1
Flores, C1
Maguilnik, I1
Hadlich, E1
Goldani, LZ1
Rosenman, JR1
Reynolds, JK1
Kleiman, MB1
Byington, CL1
Rittichier, KK1
Bassett, KE1
Castillo, H1
Glasgow, TS1
Daly, J1
Pavia, AT1
Vercaigne, LM1
Ariano, RE1
Zacharias, JM1
Lanao, JM1
Calvo, MV1
Mesa, JA1
Martín-Suárez, A1
Carbajosa, MT1
Miguelez, F1
Domínguez-Gil, A1
Arnold, DM1
Smaill, F1
Warkentin, TE1
Christjanson, L1
Walker, I1
Orsini, JA1
Spencer, P1
Shah, S1
Shah, V1
Haritova, AM1
Djeneva, HA1
Lashev, LD1
Sotirova, PG1
Gurov, BI1
Dyankov, VN1
Kaiser, AM1
Schultsz, C1
Kruithof, GJ1
Debets-Ossenkopp, Y1
Vandenbroucke-Grauls, C1
Reshed'ko, GK1
Sifakis, S1
Angelakis, E1
Makrigiannakis, A1
Orfanoudaki, I1
Christakis-Hampsas, M1
Katonis, P1
Tsatsakis, A1
Koumantakis, E1
Bernardini, J1
Bender, F1
Florio, T1
Sloand, J1
Palmmontalbano, L1
Fried, L1
Piraino, B1
Qamruddin, AO1
Alkawash, MA1
Soothill, JS1
Rajendran, SD1
Rao, YM1
Karthikeyan, VP1
Jones, SL1
Nguyen, VK1
Nguyen, TM1
Athan, E1
Shivaprakasha, S1
Radhakrishnan, K1
Kamath, P1
Karim, P1
Alvarez, JR1
Lamba, S1
Dyer, KY1
Apuzzio, JJ1
Bolisetty, S1
Agarwal, A1
Arnell, K1
Wester, T1
Tsai, TY1
Chang, SC1
Hsueh, PR1
Feng, NH1
Wang, JT1
Afshari, NA1
Ma, JJ1
Duncan, SM1
Pineda, R1
Starr, CE1
Decroos, FC1
Johnson, CS1
Adelman, RA1
Francetić, I1
Kalenić, S1
Huić, M1
Mercep, I1
Makar-Ausperger, K1
Likić, R1
Erdeljić, V1
Tripković, V1
Simić, P1
García, DC1
Woloj, GM1
Piñeiro, S1
Sordelli, DO1
Kaufman, S1
Raz, R2
Adawi, M1
Romano, S1
Elhanan, K1
Siplovich, L1
Chenoweth, CE2
Bradley, SF2
Terpenning, MS2
Zarins, LT1
Ramsey, MA1
Schaberg, DR1
Kauffman, CA2
Wan, JY1
Jorgensen, KA1
Carta, F1
Pinna, A1
Zanetti, S1
Carta, A1
Sotgiu, M1
Fadda, G1
Dryden, M1
Eykyn, SJ1
Alvarez, M1
Mendoza, MC1
Klein, JD1
Eppes, SC1
Fisk, KL1
Tholl, DA1
Shikuma, LR1
Miller, TQ1
Woodward, JM1
Cerra, FB1
Zaske, DE1
Ismaeel, NA1
Tayeri, T1
Kelly, LD1
Watling, SM1
Kisor, DF1
Sidhu, JS1
Charles, BG1
Triggs, EJ1
Tudehope, DI1
Gray, PH1
Steer, PA1
Herbrecht, R1
Blaise, D1
Espinouse, D1
Leblond, V1
Sadoun, A1
Sauvage, C1
Cordonnier, C1
Minozzi, C1
Colardyn, F1
Covi, M1
Velluti, G1
Rodriguez-Noriega, E1
Esparza-Ahumada, S1
Morfin-Otero, R1
Beaucaire, G1
Carbon, C1
Botha, P1
Venter, M1
Eisele, G1
Bailie, GR1
Kawula, TH1
Lelivelt, MJ1
Orndorff, PE1
Domínguez, H1
Vogel, BF1
Gram, L1
Hoffmann, S1
Schaebel, S1
Shapiro, DS1
Brooks, PE1
Coffey, DM1
Browne, KF1
Spraul, CW1
Lang, GE1
Lang, GK1
Tan, DT1
Lee, CP1
Lim, AS1
Miller, JM1
Novy, C1
Hiott, M1
Thomson, AH1
Duncan, N1
Silverstein, B1
Alcock, S1
Jodrell, D1
Stack, AM1
Saladino, RA1
Siber, GR1
Thompson, C1
Marra, MN1
Novitsky, TJ1
Fleisher, GR1
Cornwell, EE1
Belzberg, H1
Berne, TV1
Kern, JW1
Henriques, G1
Asensio, JA1
Demetriades, D1
Mastroianni, A1
Coronado, O1
Nanetti, A1
Manfredi, R1
Chiodo, F1
MacConnachie, AM1
Garrison, MW1
Anderson, DE1
Campbell, DM1
Carroll, KC1
Malone, CL1
Anderson, JD1
Hollis, RJ1
Pfaller, MA1
Richardson, JD1
Kallová, J1
Kettner, M1
Macicková, T1
Milosovic, P1
Langsádl, L1
Nettles, RE1
Sexton, DJ1
Palmer, LB1
Smaldone, GC1
Simon, SR1
O'Riordan, TG1
Cuccia, A1
Schacht, J1
Smith, K1
Rindone, JP1
Yap, KP1
Tan, ML1
Tan, CE1
Raisis, AL1
Hodgson, JL1
Hodgson, DR1
Fogel, MA1
Nussbaum, PB1
Feintzeig, ID1
Hunt, WA1
Gavin, JP1
Kim, RC1
Iwata, M1
Tateda, K1
Matsumoto, T1
Furuya, N1
Mizuiri, S1
Yamaguchi, K1
Hay, AJ1
Lo, TY1
Tang, GJ1
Tang, JJ1
Lin, BS1
Kong, CW1
Lee, TY1
Alexandrakis, G1
Alfonso, EC1
Miller, D1
Wilcox, RA1
Chin, GK1
Segasothy, M1
Pession, A1
Castellini, C1
Prete, A1
Locatelli, F1
Urbini, B1
Paolucci, G1
Almuneef, MA1
Baltimore, RS1
Farrel, PA1
Reagan-Cirincione, P1
Dembry, LM1
Kern, WV1
Heiss, M1
Steinbach, G1
Tripodi, MF1
Andreana, A1
Sarnataro, G1
Ragone, E1
Adinolfi, LE1
Utili, R1
Miron, D1
Papa, V1
Aragona, P1
Scuderi, AC1
Blanco, AR1
Zola, P1
Di, BA1
Santocono, M1
Milazzo, G1
Kim, JH1
Kim, SW1
Kang, HR1
Bae, GB1
Park, JH1
Nam, EJ1
Kang, YM1
Lee, JM1
Kim, NS1
Miguélez, M1
Domínguez-Ortega, L1
del Palacio Medel, A1
García Aguado, JM1
Bateman, JM1
Rainford, DJ1
Masterton, RG1
King, JW1
White, MC1
Todd, JR1
Conrad, SA1
Jensen, PD1
Edgren, BE1
Brundage, RC1
Kelsey, SM1
Shaw, E1
Newland, AC1
Castan, R1
Resnikoff, S1
Guillemot de Liniers, F1
Huguet, P1
Peyramaure, F1
Toscano, MA1
Minneci, M1
Salmeri, M1
Nicoletti, G1
Cheadle, WG1
Hanasawa, K1
Gallinaro, RN1
Nimmanwudipong, T1
Kodama, M1
Polk, HC1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Aerosolized Antibiotics in the Treatment of Ventilator Associated Pneumonia: A Pilot Study[NCT02478710]Phase 416 participants (Actual)Interventional2015-06-30Terminated
Contribution of Fast Molecular Bacterial Identification by Real-time PCR in Managing of Postoperative Acute Endophthalmitis[NCT02850653]150 participants (Anticipated)Interventional2007-11-30Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

13 reviews available for gentamicin and Gram-Negative Bacterial Infections

ArticleYear
Comparison of topical mupirocin and gentamicin in the prevention of peritoneal dialysis-related infections: A systematic review and meta-analysis.
    American journal of surgery, 2018, Volume: 215, Issue:1

    Topics: Administration, Topical; Anti-Bacterial Agents; Antibiotic Prophylaxis; Catheter-Related Infections;

2018
Aminoglycoside toxicity in neonates: something to worry about?
    Expert review of anti-infective therapy, 2014, Volume: 12, Issue:3

    Topics: Amikacin; Aminoglycosides; Animals; Anti-Infective Agents; Drug-Related Side Effects and Adverse Rea

2014
Improving the outcome of bacterial meningitis in newborn infants in Africa: reflections on recent progress.
    Current opinion in infectious diseases, 2015, Volume: 28, Issue:3

    Topics: Africa; Anti-Bacterial Agents; C-Reactive Protein; Drug Resistance, Bacterial; Female; Gentamicins;

2015
Susceptibility of Gram-negative bacteria to isepamicin: a systematic review.
    Expert review of anti-infective therapy, 2012, Volume: 10, Issue:2

    Topics: Adult; Amikacin; Anti-Bacterial Agents; Child; Child, Preschool; Databases, Bibliographic; Drug Admi

2012
Intraventricular antibiotics for bacterial meningitis in neonates.
    The Cochrane database of systematic reviews, 2012, Jul-11, Issue:7

    Topics: Anti-Bacterial Agents; Cerebral Ventriculitis; Gentamicins; Gram-Negative Bacterial Infections; Huma

2012
Peritonitis caused by Roseomonas in a patient undergoing automated peritoneal dialysis: case report and literature review.
    Internal medicine (Tokyo, Japan), 2012, Volume: 51, Issue:13

    Topics: Aged; Anti-Bacterial Agents; Ciprofloxacin; Female; Gentamicins; Gram-Negative Bacterial Infections;

2012
Agrobacterium radiobacter bacteremia in pediatric patients: case report and review.
    The Pediatric infectious disease journal, 2003, Volume: 22, Issue:2

    Topics: Bacteremia; Catheterization, Central Venous; Child; Device Removal; Drug Therapy, Combination; Femal

2003
Capnocytophaga canimorsus meningitis in a newborn: an avoidable infection.
    The Pediatric infectious disease journal, 2003, Volume: 22, Issue:2

    Topics: Ampicillin; Animals; Capnocytophaga; Cefotaxime; Dogs; Drug Therapy, Combination; Female; Follow-Up

2003
Intraventricular antibiotics for bacterial meningitis in neonates.
    The Cochrane database of systematic reviews, 2004, Oct-18, Issue:4

    Topics: Anti-Bacterial Agents; Gentamicins; Gram-Negative Bacterial Infections; Humans; Infant, Newborn; Inj

2004
A review of gentamicin use in neonates.
    Neonatal network : NN, 1993, Volume: 12, Issue:7

    Topics: Gentamicins; Gram-Negative Bacterial Infections; Humans; Infant, Newborn

1993
Aminoglycoside ototoxicity: prevention in sight?
    Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 1998, Volume: 118, Issue:5

    Topics: Animals; Anti-Bacterial Agents; Antitubercular Agents; Clinical Trials as Topic; Cochlea; Disease Mo

1998
Once daily dosing of gentamicin in infants and children.
    The Pediatric infectious disease journal, 2001, Volume: 20, Issue:12

    Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Cost-Benefit Analysis; Gentamicins; Gram

2001
Two episodes of Stenotrophomonas maltophilia endocarditis of prosthetic mitral valve: report of a case and review of the literature.
    Journal of Korean medical science, 2002, Volume: 17, Issue:2

    Topics: Adult; Anti-Bacterial Agents; Bioprosthesis; Endocarditis, Bacterial; Gentamicins; Gram-Negative Bac

2002

Trials

17 trials available for gentamicin and Gram-Negative Bacterial Infections

ArticleYear
Antimicrobial stewardship in paediatric oncology: Impact on optimising gentamicin use in febrile neutropenia.
    Pediatric blood & cancer, 2018, Volume: 65, Issue:2

    Topics: Child; Child, Preschool; Febrile Neutropenia; Female; Gentamicins; Gram-Negative Bacteria; Gram-Nega

2018
Does the availability of therapeutic drug monitoring, computerised dose recommendation and prescribing decision support services promote compliance with national gentamicin prescribing guidelines?
    Internal medicine journal, 2015, Volume: 45, Issue:1

    Topics: Aged; Anti-Bacterial Agents; Decision Support Systems, Clinical; Dose-Response Relationship, Drug; D

2015
A prospective comparative study of gentamicin- and amikacin-induced nephrotoxicity in patients with normal baseline renal function.
    Fundamental & clinical pharmacology, 2009, Volume: 23, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Creatinine; Dose-Respon

2009
Chemoprophylactic and bactericidal efficacy of 80 mg gentamicin in a single and once-daily dosing.
    Archives of gynecology and obstetrics, 2005, Volume: 272, Issue:3

    Topics: Adult; Amniotic Fluid; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cephalosporins; Cesarean Secti

2005
Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients.
    Journal of the American Society of Nephrology : JASN, 2005, Volume: 16, Issue:2

    Topics: Administration, Topical; Adult; Aged; Analysis of Variance; Catheters, Indwelling; Confidence Interv

2005
Evaluation of target concentration intervention strategy of gentamicin therapy in a malnourished patient population of south India.
    The Indian journal of medical research, 2005, Volume: 122, Issue:6

    Topics: Adult; Anti-Bacterial Agents; Female; Gentamicins; Gram-Negative Bacterial Infections; Humans; Male;

2005
Intravenous administration of gentamicin once daily versus thrice daily in adults.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1995, Volume: 14, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Drug Administration Schedule; Drug Monitoring; Female; G

1995
Gentamicin once-daily versus thrice-daily in children.
    The Journal of antimicrobial chemotherapy, 1995, Volume: 35, Issue:2

    Topics: Adolescent; Child; Child, Preschool; Drug Administration Schedule; Drug Tolerance; Female; Gentamici

1995
Isepamicin once daily plus ceftriaxone versus amikacin plus ceftriaxone in febrile neutropenic patients.
    Journal of chemotherapy (Florence, Italy), 1995, Volume: 7 Suppl 2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bone Marrow Transplanta

1995
The efficacy and safety of isepamicin and ceftazidime compared with amikacin and ceftazidime in acute lower respiratory tract infection.
    Journal of chemotherapy (Florence, Italy), 1995, Volume: 7 Suppl 2

    Topics: Acute Disease; Amikacin; Anti-Bacterial Agents; Bronchitis; Ceftazidime; Cross Infection; Drug Admin

1995
Comparison of the efficacy and safety of isepamicin and amikacin in the treatment of acute lower respiratory tract infections caused by gram-negative organisms.
    Journal of chemotherapy (Florence, Italy), 1995, Volume: 7 Suppl 2

    Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bronchitis; Drug Administration Sch

1995
Comparison of the efficacy and safety of isepamicin and amikacin in the treatment of skin and skin structure infections.
    Journal of chemotherapy (Florence, Italy), 1995, Volume: 7 Suppl 2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Drug Administration Sch

1995
Evaluation of the efficacy and safety of isepamicin compared with amikacin in the treatment of nosocomial pneumonia and septicaemia.
    Journal of chemotherapy (Florence, Italy), 1995, Volume: 7 Suppl 2

    Topics: Amikacin; Anti-Bacterial Agents; Bacteremia; Cross Infection; Drug Therapy, Combination; Female; Gen

1995
Overview of the efficacy of isepamicin in the adult core clinical trial programme.
    Journal of chemotherapy (Florence, Italy), 1995, Volume: 7 Suppl 2

    Topics: Abdomen; Adult; Aged; Amikacin; Anti-Bacterial Agents; Bacteremia; Drug Administration Schedule; Fem

1995
Aerosolized antibiotics in mechanically ventilated patients: delivery and response.
    Critical care medicine, 1998, Volume: 26, Issue:1

    Topics: Adult; Aerosols; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Case-Control Studies; Chr

1998
Treatment of acute bacterial conjunctivitis with topical netilmicin.
    Cornea, 2002, Volume: 21, Issue:1

    Topics: Acute Disease; Administration, Topical; Anti-Bacterial Agents; Bacteria; Conjunctivitis, Bacterial;

2002
Aztreonam plus vancomycin versus gentamicin plus piperacillin as empirical therapy for the treatment of fever in neutropenic patients: a randomised controlled study.
    Journal of chemotherapy (Florence, Italy), 1992, Volume: 4, Issue:2

    Topics: Adult; Aztreonam; Bacteremia; Drug Therapy, Combination; Fever; Gentamicins; Gram-Negative Bacteria;

1992

Other Studies

100 other studies available for gentamicin and Gram-Negative Bacterial Infections

ArticleYear
Characteristics and Outcomes of Patients with Delftia acidovorans Infections: a Retrospective Cohort Study.
    Microbiology spectrum, 2022, 08-31, Volume: 10, Issue:4

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Ceftazidime; Colistin; Delftia acidovorans; Female;

2022
Infective endocarditis caused by Capnocytophaga canimorsus; a case report.
    BMC infectious diseases, 2019, Nov-04, Volume: 19, Issue:1

    Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Bites and Stings; Blood Culture; Capnocytophaga; Ce

2019
Antimicrobial resistance and virulence genes profiles of Arcobacter butzleri strains isolated from back yard chickens and retail poultry meat in Chile.
    Letters in applied microbiology, 2021, Volume: 72, Issue:2

    Topics: Animals; Anti-Bacterial Agents; Arcobacter; Chickens; Chile; Ciprofloxacin; Drug Resistance, Bacteri

2021
Prevalence and risk factors for antimicrobial resistance among newborns with gram-negative sepsis.
    PloS one, 2021, Volume: 16, Issue:8

    Topics: Ampicillin; Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Multiple, Bacterial; Ethiopia; F

2021
Neonatal Bacteremia Caused by an Unusual Suspect.
    Clinical pediatrics, 2017, Volume: 56, Issue:10

    Topics: Ampicillin; Anti-Bacterial Agents; Bacteremia; Capnocytophaga; Cefotaxime; Female; Gentamicins; Gram

2017
Is gentamicin safe and effective for severe community-acquired pneumonia? An 8-year retrospective cohort study.
    International journal of antimicrobial agents, 2018, Volume: 51, Issue:6

    Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Community-Acquired Infe

2018
Mixed pneumonic plague and nosocomial MDR-bacterial infection of lung: a rare case report.
    BMC pulmonary medicine, 2018, May-29, Volume: 18, Issue:1

    Topics: Anti-Bacterial Agents; Ciprofloxacin; Coinfection; Cross Infection; Drug Resistance, Multiple, Bacte

2018
Screening for colonisation with gentamicin-resistant Gram-negative organisms on the neonatal unit: does positive screening predict sepsis?
    Archives of disease in childhood. Fetal and neonatal edition, 2019, Volume: 104, Issue:1

    Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Gentamicins; Gram-Negative Bacteria; Gram-Negativ

2019
Gentamicin as Empirical Treatment in Hemodialysis Patients: Safety, Pharmacokinetics, and Pharmacodynamics.
    Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 2019, Volume: 23, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Catheter-Related Infections; Fema

2019
Generalized and Prolonged Use of Gentamicin-Lock Therapy Reduces Hemodialysis Catheter-Related Infections Due to Gram Negatives.
    Nephron, 2019, Volume: 143, Issue:2

    Topics: Adult; Anti-Bacterial Agents; Bacteremia; Catheter-Related Infections; Catheters, Indwelling; Cohort

2019
Synergistic activity between Triphala and selected antibiotics against drug resistant clinical isolates.
    BMC complementary and alternative medicine, 2019, Aug-02, Volume: 19, Issue:1

    Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Drug Synergism; Gentamicins; Gram-Negative Bacter

2019
Antibiotic selection for the treatment of infectious complications of implant-based breast reconstruction.
    Annals of plastic surgery, 2013, Volume: 71, Issue:2

    Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Breast Implantation; Breast Implants; Devi

2013
A comparative study of clinical Aeromonas dhakensis and Aeromonas hydrophila isolates in southern Taiwan: A. dhakensis is more predominant and virulent.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2014, Volume: 20, Issue:7

    Topics: Adult; Aeromonas; Aged; Animals; Anti-Bacterial Agents; Biofilms; Caenorhabditis elegans; Ceftriaxon

2014
[Cardiobacterium hominis septic arthritis].
    Medecine et maladies infectieuses, 2014, Volume: 44, Issue:3

    Topics: Amoxicillin; Anti-Bacterial Agents; Arthritis, Infectious; Bacteremia; Cardiobacterium; Cervical Ver

2014
Bacteria causing ventriculoperitoneal shunt infections in a Kenyan population.
    Journal of neurosurgery. Pediatrics, 2015, Volume: 15, Issue:2

    Topics: Adolescent; Ampicillin; Anti-Bacterial Agents; Child; Child, Preschool; Chloramphenicol; Ciprofloxac

2015
Best practice aminoglycoside monitoring.
    Internal medicine journal, 2015, Volume: 45, Issue:7

    Topics: Drug Monitoring; Drug Prescriptions; Female; Gentamicins; Gram-Negative Bacterial Infections; Guidel

2015
Impact of a Multimodal Approach in Prevention of Surgical Site Infection in Hepatic Transplant Recipients.
    Transplantation proceedings, 2016, Volume: 48, Issue:2

    Topics: Administration, Cutaneous; Adult; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents, Local; A

2016
Comparison of ß-lactam plus aminoglycoside versus ß-lactam plus fluoroquinolone empirical therapy in serious nosocomial infections due to Gram-negative bacilli.
    Journal of chemotherapy (Florence, Italy), 2017, Volume: 29, Issue:1

    Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Cohort Studies; Critical Illness;

2017
Fatal Neisseria macacae infective endocarditis: first report.
    Infection, 2017, Volume: 45, Issue:3

    Topics: Abscess; Aged; Anti-Bacterial Agents; Aortic Valve; Ceftriaxone; Endocarditis, Bacterial; Fatal Outc

2017
Acute tenosynovitis of the ankle due to Capnocytophaga cynodegmi/canimorsus as identified by 16S rRNA gene sequencing.
    Joint bone spine, 2008, Volume: 75, Issue:6

    Topics: Abscess; Acute Disease; Administration, Oral; Ankle; Anti-Bacterial Agents; Capnocytophaga; Doxycycl

2008
Chromobacterium violaceum infection in a provincial hospital in Sri Lanka.
    The Ceylon medical journal, 2008, Volume: 53, Issue:4

    Topics: Anti-Bacterial Agents; Bacteremia; Chromobacterium; Fatal Outcome; Gentamicins; Gram-Negative Bacter

2008
Recurrent and relapsing peritonitis: causative organisms and response to treatment.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2009, Volume: 54, Issue:4

    Topics: Adult; Aged; Anti-Bacterial Agents; Cefazolin; Ceftazidime; Female; Gentamicins; Gram-Negative Bacte

2009
The in-vivo antibacterial activity of ceftazidime (Gr 20263)--a comparison with other new beta-lactam antibiotics and gentamicin.
    The Journal of antimicrobial chemotherapy, 1981, Volume: 8 Suppl B

    Topics: Agar; Animals; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Ceftazidime; Cephalosporin

1981
Ceftazidime in Gram-negative infections: three case reports.
    The Journal of antimicrobial chemotherapy, 1981, Volume: 8 Suppl B

    Topics: Adult; Aged; Anti-Bacterial Agents; Ceftazidime; Chloramphenicol; Fatal Outcome; Female; Gentamicins

1981
Concordance of Gastrointestinal Tract Colonization and Subsequent Bloodstream Infections With Gram-negative Bacilli in Very Low Birth Weight Infants in the Neonatal Intensive Care Unit.
    The Pediatric infectious disease journal, 2010, Volume: 29, Issue:9

    Topics: Anti-Bacterial Agents; Bacteremia; Cohort Studies; Female; Gastrointestinal Tract; Gentamicins; Gram

2010
[Importance of exit site care as peritonitis prophylaxis: experience in our centre].
    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2010, Volume: 30, Issue:5

    Topics: Administration, Topical; Antibiotic Prophylaxis; Candidiasis; Catheter-Related Infections; Catheters

2010
Challenges in the clinical management of blood-culture negative endocarditis: case of Bartonella henselae infection.
    The American journal of medicine, 2011, Volume: 124, Issue:3

    Topics: Anti-Bacterial Agents; Antibodies, Bacterial; Aortic Valve; Bartonella henselae; Cat-Scratch Disease

2011
Neurosurgical gram-negative bacillary ventriculitis and meningitis: a retrospective study evaluating the efficacy of intraventricular gentamicin therapy in 31 consecutive cases.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2011, Volume: 52, Issue:11

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Cerebral Ventriculitis; Cerebrospinal Fluid; Drug Th

2011
Gentamicin and ototoxicity: why this drug is still in use.
    The Medical journal of Australia, 2012, Jun-18, Volume: 196, Issue:11

    Topics: Anti-Bacterial Agents; Australia; Dose-Response Relationship, Drug; Gentamicins; Gram-Negative Bacte

2012
Antimicrobial susceptibility of non-fermenting Gram-negative isolates to isepamicin in a region with high antibiotic resistance.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2012, Volume: 31, Issue:11

    Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Gentamicins; Gram-Negative Bacteria; Gram-Negativ

2012
Comparison of E-test with other conventional susceptibility testing methods for ciprofloxacin and gentamicin against gram negative enteric bacilli.
    African journal of medicine and medical sciences, 2012, Volume: 41, Issue:2

    Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Microbial; Gentamicins; Gram-Negative Bacteri

2012
Evaluating effectiveness of antibiotic polymethylmethacrylate beads in achieving wound sterilization and graft preservation in patients with early and late vascular graft infections.
    Surgery, 2013, Volume: 153, Issue:5

    Topics: Administration, Topical; Aged; Aged, 80 and over; Amputation, Surgical; Anti-Bacterial Agents; Antis

2013
The effect of antibiotic rotation on colonization with antibiotic-resistant bacilli in a neonatal intensive care unit.
    Pediatrics, 2002, Volume: 110, Issue:4

    Topics: Anti-Bacterial Agents; Ceftazidime; Cross Infection; Drug Resistance, Bacterial; Drug Resistance, Mu

2002
Microbiology of choledochal bile in patients with choledocholithiasis admitted to a tertiary hospital.
    Journal of gastroenterology and hepatology, 2003, Volume: 18, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Brazil; Cephalosporins; Cholangio

2003
Serious bacterial infections in febrile infants younger than 90 days of age: the importance of ampicillin-resistant pathogens.
    Pediatrics, 2003, Volume: 111, Issue:5 Pt 1

    Topics: Ampicillin Resistance; Bacteremia; Bacterial Infections; Cefotaxime; Drug Resistance, Bacterial; Fev

2003
Bayesian pharmacokinetics of gentamicin in a haemodialysis population.
    Clinical pharmacokinetics, 2004, Volume: 43, Issue:3

    Topics: Adult; Aged; Anti-Bacterial Agents; Bayes Theorem; Gentamicins; Gram-Negative Bacterial Infections;

2004
Pharmacokinetic basis for the use of extended interval dosage regimens of gentamicin in neonates.
    The Journal of antimicrobial chemotherapy, 2004, Volume: 54, Issue:1

    Topics: Algorithms; Anti-Bacterial Agents; Bayes Theorem; Birth Weight; Gentamicins; Gram-Negative Bacterial

2004
Cardiobacterium hominis endocarditis associated with very severe thrombocytopenia and platelet autoantibodies.
    American journal of hematology, 2004, Volume: 76, Issue:4

    Topics: Ampicillin; Antigens, Human Platelet; Aortic Valve Stenosis; Autoantibodies; Autoimmune Diseases; Ba

2004
Epidemiology of aminoglycoside resistance in a large animal hospital.
    Equine veterinary journal, 1997, Volume: 29, Issue:4

    Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Colony Count, Microbial; Drug Resistance, Bacterial

1997
Pharmacokinetics of gentamicin and apramycin in turkeys roosters and hens in the context of pharmacokinetic-pharmacodynamic relationships.
    Journal of veterinary pharmacology and therapeutics, 2004, Volume: 27, Issue:5

    Topics: Animals; Cross-Over Studies; Drug Interactions; Escherichia coli; Female; Gentamicins; Gram-Negative

2004
Carriage of resistant microorganisms in repatriates from foreign hospitals to The Netherlands.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2004, Volume: 10, Issue:11

    Topics: Carrier State; Drug Resistance, Bacterial; Enterococcus; Gentamicins; Gram-Negative Bacteria; Gram-N

2004
[Aminoglycoside resistance in gramnegative pathogens of nosocomial infections in Russia].
    Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2004, Volume: 49, Issue:5

    Topics: Acetyltransferases; Aminoglycosides; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Bacter

2004
Antibiotic susceptibility of Stenotrophomonas maltophilia in the presence of lactoferrin.
    Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:10

    Topics: Anti-Bacterial Agents; Cystic Fibrosis; Drug Therapy, Combination; Gentamicins; Gram-Negative Bacter

2005
Prevalence of multiresistant Gram-negative organisms in a surgical hospital in Ho Chi Minh City, Vietnam.
    Tropical medicine & international health : TM & IH, 2006, Volume: 11, Issue:11

    Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporin Resistance; Ciprofloxacin; Cross Infection; Dr

2006
Late prosthetic valve endocarditis due to Cardiobacterium hominis, an unusual complication.
    Indian journal of medical microbiology, 2007, Volume: 25, Issue:1

    Topics: Anti-Bacterial Agents; Cardiobacterium; Endocarditis, Bacterial; Gentamicins; Gram-Negative Bacteria

2007
An unusual case of urinary tract infection in a pregnant woman with Photobacterium damsela.
    Infectious diseases in obstetrics and gynecology, 2006, Volume: 2006

    Topics: Adult; Anti-Bacterial Agents; Cefazolin; Female; Gentamicins; Gram-Negative Bacterial Infections; Hu

2006
Subclinical kidney injury incites endotoxin hyperresponsiveness.
    American journal of physiology. Renal physiology, 2007, Volume: 293, Issue:1

    Topics: Acute Kidney Injury; Animals; Anti-Bacterial Agents; Endotoxins; Gentamicins; Gram-Negative Bacteria

2007
Treatment of cerebrospinal fluid shunt infections in children using systemic and intraventricular antibiotic therapy in combination with externalization of the ventricular catheter: efficacy in 34 consecutively treated infections.
    Journal of neurosurgery, 2007, Volume: 107, Issue:3 Suppl

    Topics: Adolescent; Anti-Bacterial Agents; Cerebrospinal Fluid Shunts; Child; Child, Preschool; Gentamicins;

2007
In vitro activity of isepamicin and other aminoglycosides against clinical isolates of Gram-negative bacteria causing nosocomial bloodstream infections.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2007, Volume: 40, Issue:6

    Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Cross Infection; Gentamicins; Gram-Negative Bact

2007
Trends in resistance to ciprofloxacin, cefazolin, and gentamicin in the treatment of bacterial keratitis.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2008, Volume: 24, Issue:2

    Topics: Anti-Bacterial Agents; Cefazolin; Ciprofloxacin; Drug Resistance, Bacterial; Eye Infections, Bacteri

2008
Impact of aminoglycoside cycling in six tertiary intensive care units: prospective longitudinal interventional study.
    Croatian medical journal, 2008, Volume: 49, Issue:2

    Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Cost-Benefit Analysis; Croatia; Drug Resistance, M

2008
An 8-year study of resistance to amikacin in gram-negative bacilli isolates from patients with nosocomial infection at one hospital in Argentina.
    Journal of medical microbiology, 1995, Volume: 42, Issue:4

    Topics: Acinetobacter; Amikacin; Argentina; Cross Infection; DNA, Bacterial; Drug Resistance, Microbial; Ent

1995
Colonization and transmission of high-level gentamicin-resistant enterococci in a long-term care facility.
    Infection control and hospital epidemiology, 1994, Volume: 15, Issue:11

    Topics: Colony Count, Microbial; Cross Infection; DNA, Bacterial; Drug Resistance, Microbial; Enterococcus;

1994
Colonization and infection with antibiotic-resistant bacteria in a long-term care facility.
    Journal of the American Geriatrics Society, 1994, Volume: 42, Issue:10

    Topics: Aged; Bacterial Infections; Carrier State; Drug Resistance, Microbial; Enterococcus; Female; Gentami

1994
Corneal ulcer caused by Aeromonas species.
    American journal of ophthalmology, 1994, Oct-15, Volume: 118, Issue:4

    Topics: Aeromonas hydrophila; Contact Lenses; Cornea; Corneal Ulcer; Eye Infections, Bacterial; Eye Injuries

1994
Short-course gentamicin in gram-negative CAPD peritonitis.
    Lancet (London, England), 1993, Feb-20, Volume: 341, Issue:8843

    Topics: Gentamicins; Gram-Negative Bacterial Infections; Humans; Peritoneal Dialysis, Continuous Ambulatory;

1993
Molecular epidemiology of two genes encoding 3-N-aminoglycoside acetyltransferases AAC(3)I and AAC(3)II among gram-negative bacteria from a Spanish hospital.
    European journal of epidemiology, 1993, Volume: 9, Issue:6

    Topics: Acetyltransferases; Blotting, Southern; DNA Probes; DNA, Bacterial; Drug Resistance, Microbial; Elec

1993
Ochrobactrum anthropi bacteremia in a child.
    Delaware medical journal, 1993, Volume: 65, Issue:8

    Topics: Bacteremia; Ceftazidime; Child; Drug Therapy, Combination; Female; Gentamicins; Gram-Negative Bacter

1993
Physiologic response of stress and aminoglycoside clearance in critically ill patients.
    Critical care medicine, 1993, Volume: 21, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminoglycosides; Blood Urea Nitrogen; Cross-Sectional St

1993
Resistance of bacteria from human faecal flora to antimicrobial agents.
    The Journal of tropical medicine and hygiene, 1993, Volume: 96, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ampicillin Resistance; Child; Cross Infection; Drug Resi

1993
Alcaligenes faecalis corneal ulcer in a patient with cicatricial pemphigoid.
    American journal of ophthalmology, 1993, Feb-15, Volume: 115, Issue:2

    Topics: Alcaligenes; Cefazolin; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Gentami

1993
Population pharmacokinetics: development of a medical intensive care unit-specific gentamicin dosing nomogram.
    The Annals of pharmacotherapy, 1993, Volume: 27, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Female; Gentamicins; Gram-Negative Bacterial Infections; Hospitals,

1993
Assessment of bioelectrical impedance for individualizing gentamicin therapy in neonates.
    European journal of clinical pharmacology, 1993, Volume: 44, Issue:3

    Topics: Electric Impedance; Gentamicins; Gram-Negative Bacterial Infections; Humans; Infant, Newborn; Predic

1993
Cardiobacterium hominis as a cause of bacterial endocarditis.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1996, Volume: 86, Issue:1

    Topics: Adult; Anti-Bacterial Agents; Endocarditis, Bacterial; Gentamicins; Gram-Negative Bacterial Infectio

1996
Successful treatment of Aeromonas hydrophila peritoneal dialysis-associated peritonitis using intermittent intraperitoneal gentamicin.
    Clinical nephrology, 1995, Volume: 44, Issue:6

    Topics: Aeromonas hydrophila; Aged; Anti-Bacterial Agents; Gentamicins; Gram-Negative Bacterial Infections;

1995
Using a new inbred fish model and cultured fish tissue cells to study Aeromonas hydrophila and Yersinia ruckeri pathogenesis.
    Microbial pathogenesis, 1996, Volume: 20, Issue:2

    Topics: Aeromonas hydrophila; Animals; Anti-Bacterial Agents; Blotting, Southern; Cells, Cultured; Cyprinida

1996
Shewanella alga bacteremia in two patients with lower leg ulcers.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1996, Volume: 22, Issue:6

    Topics: Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Bacteremia; Cefuroxime; Female; Gentamic

1996
Peripartum bacteremia with CDC group HB-5 (Pasteurella bettyae).
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1996, Volume: 22, Issue:6

    Topics: Adult; Amoxicillin; Ampicillin; Anti-Bacterial Agents; Bacteremia; Female; Gentamicins; Gram-Negativ

1996
Xanthomonas maltophilia keratitis associated with contact lenses.
    The CLAO journal : official publication of the Contact Lens Association of Ophthalmologists, Inc, 1996, Volume: 22, Issue:3

    Topics: Adult; Anti-Bacterial Agents; Contact Lenses; Cornea; Corneal Ulcer; Drug Therapy, Combination; Eye

1996
Corneal ulcers in two institutions in Singapore: analysis of causative factors, organisms and antibiotic resistance.
    Annals of the Academy of Medicine, Singapore, 1995, Volume: 24, Issue:6

    Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Chloramphenicol Resistance; Cont

1995
Case of bacterial endophthalmitis caused by an Agrobacterium radiobacter-like organism.
    Journal of clinical microbiology, 1996, Volume: 34, Issue:12

    Topics: Aged; Cataract Extraction; Drug Therapy, Combination; Endophthalmitis; Gentamicins; Gram-Negative Ba

1996
Antimicrobial practice. Development of guidelines for gentamicin dosing.
    The Journal of antimicrobial chemotherapy, 1996, Volume: 38, Issue:5

    Topics: Anti-Bacterial Agents; Bacteremia; Drug Administration Schedule; Female; Gentamicins; Gram-Negative

1996
A comparison of bactericidal/permeability-increasing protein variant versus recombinant endotoxin-neutralizing protein for the treatment of Escherichia coli sepsis in rats .
    Critical care medicine, 1997, Volume: 25, Issue:1

    Topics: Animals; Anti-Infective Agents; Ceftriaxone; Disease Models, Animal; Drug Therapy, Combination; Esch

1997
Aminoglycoside levels in critically ill surgical patients: the implications of physiologic criteria of sepsis.
    Southern medical journal, 1997, Volume: 90, Issue:1

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; APACHE; Child; Female; Gentamicins; Gram-Negative Ba

1997
Agrobacterium radiobacter pneumonia in a patient with HIV infection.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1996, Volume: 15, Issue:12

    Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; CD4 Lymphocyte Count; Ceftriaxone; Ce

1996
Gentamicin once a day.
    Intensive & critical care nursing, 1996, Volume: 12, Issue:6

    Topics: Anti-Bacterial Agents; Drug Administration Schedule; Drug Monitoring; Gentamicins; Gram-Negative Bac

1996
Stenotrophomonas maltophilia: emergence of multidrug-resistant strains during therapy and in an in vitro pharmacodynamic chamber model.
    Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:12

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ceftazidime; Ciprofloxacin; Clavulanic Acid; Clavulani

1996
Failure to clear a Roseomonas line infection with antibiotic therapy.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1997, Volume: 25, Issue:1

    Topics: Adult; Anti-Bacterial Agents; Catheterization, Central Venous; Ceftazidime; Drug Therapy, Combinatio

1997
Aminoglycoside resistance. Enzymatic mechanisms in clinical bacterial strains in Slovakia during the last decade.
    FEMS immunology and medical microbiology, 1997, Volume: 19, Issue:1

    Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Enzymes; Gentamicins; Gram-Negative Bacteria; Gra

1997
Successful treatment of Edwardsiella tarda prosthetic valve endocarditis in a patient with AIDS.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1997, Volume: 25, Issue:4

    Topics: Adult; AIDS-Related Opportunistic Infections; Ampicillin; Cefotaxime; Ciprofloxacin; Drug Therapy, C

1997
A gentamicin order form improves its use.
    The Western journal of medicine, 1998, Volume: 168, Issue:6

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Arizona; Dose-Response Relationship, Drug; Drug Moni

1998
Survey of aerobic bacterial infections in paediatric surgical intensive care unit patients.
    Annals of the Academy of Medicine, Singapore, 1998, Volume: 27, Issue:2

    Topics: Ampicillin Resistance; Anti-Bacterial Agents; Bacteria, Aerobic; Bacterial Infections; Child; Child,

1998
Serum gentamicin concentrations in compromised neonatal foals.
    Equine veterinary journal, 1998, Volume: 30, Issue:4

    Topics: Animals; Animals, Newborn; Anti-Bacterial Agents; Fluorescence Polarization Immunoassay; Gentamicins

1998
Cefazolin in chronic hemodialysis patients: a safe, effective alternative to vancomycin.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 1998, Volume: 32, Issue:3

    Topics: Ambulatory Care; Anti-Bacterial Agents; Bacteremia; Cefazolin; Cephalosporins; Drug Therapy, Combina

1998
Primary Shewanella alga septicemia in a patient on hemodialysis.
    Journal of clinical microbiology, 1999, Volume: 37, Issue:6

    Topics: Anti-Bacterial Agents; Bacteremia; Cefazolin; Drug Therapy, Combination; Escherichia coli; Female; G

1999
Ochrobactrum anthropi meningitis in a pre-term neonate.
    The Journal of infection, 1999, Volume: 38, Issue:2

    Topics: Alcaligenes; Cefotaxime; Cephalosporins; Female; Gentamicins; Gram-Negative Bacterial Infections; Hu

1999
Factors affecting gentamicin pharmacokinetics in septic patients.
    Acta anaesthesiologica Scandinavica, 1999, Volume: 43, Issue:7

    Topics: Aged; Analysis of Variance; Anti-Bacterial Agents; Antibiotic Prophylaxis; APACHE; Blood Urea Nitrog

1999
Shifting trends in bacterial keratitis in south Florida and emerging resistance to fluoroquinolones.
    Ophthalmology, 2000, Volume: 107, Issue:8

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Ciprofloxacin; Cornea; Corneal Ulcer; Drug R

2000
Aeromonas hydrophila infection secondary to an electrical burn.
    The Medical journal of Australia, 2000, Aug-21, Volume: 173, Issue:4

    Topics: Aeromonas hydrophila; Aged; Anti-Infective Agents; Burns, Electric; Ciprofloxacin; Female; Gentamici

2000
Method using urokinase and an antibiotic to avoid device removal in central venous catheter-related infections.
    Medical and pediatric oncology, 2000, Volume: 35, Issue:4

    Topics: Adolescent; Anti-Bacterial Agents; Bone Marrow Transplantation; Catheterization, Central Venous; Chi

2000
Molecular typing demonstrating transmission of gram-negative rods in a neonatal intensive care unit in the absence of a recognized epidemic.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2001, Jan-15, Volume: 32, Issue:2

    Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Cross Infection; DNA, Bacterial; Drug Resistance

2001
Prediction of gram-negative bacteremia in patients with cancer and febrile neutropenia by means of interleukin-8 levels in serum: targeting empirical monotherapy versus combination therapy.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2001, Mar-01, Volume: 32, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteremia; Cefepime; Cephalosporins; Drug Therapy, Comb

2001
Comparative activities of isepamicin, amikacin, cefepime, and ciprofloxacin alone or in combination with other antibiotics against Stenotrophomonas maltophilia.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2001, Volume: 20, Issue:1

    Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Cefepime; Cephalosporins; Ciprofloxacin; Col

2001
[Multiple pulmonary abscesses caused by Eikenella corrodens].
    Revista clinica espanola, 1992, Volume: 191, Issue:2

    Topics: Adult; Cloxacillin; Eikenella corrodens; Gentamicins; Gram-Negative Bacterial Infections; Humans; Lu

1992
Capnocytophaga canimorus infection and acute renal failure.
    The Journal of infection, 1992, Volume: 25, Issue:1

    Topics: Acute Kidney Injury; Capnocytophaga; Gentamicins; Gram-Negative Bacterial Infections; Humans; Male;

1992
Alterations in the microbial flora and in the incidence of bacteremia at a university hospital after adoption of amikacin as the sole formulary aminoglycoside.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1992, Volume: 14, Issue:4

    Topics: Amikacin; Bacteremia; Drug Resistance, Microbial; Gentamicins; Gram-Negative Bacteria; Gram-Negative

1992
Population pharmacokinetics of gentamicin in neonates using a nonlinear, mixed-effects model.
    Pharmacotherapy, 1992, Volume: 12, Issue:3

    Topics: Gentamicins; Gram-Negative Bacterial Infections; Humans; Infant, Newborn; Metabolic Clearance Rate;

1992
[Tropical conjunctivitis: infectious etiology and validation of its clinical features].
    Revue internationale du trachome et de pathologie oculaire tropicale et subtropicale et de sante publique : organe de la Ligue contre le trachome avec la collaboration de l'International Organization against Trachoma et des organisation..., 1991, Volume: 68

    Topics: Adenoviridae Infections; Adolescent; Adult; Case-Control Studies; Child; Conjunctivitis, Bacterial;

1991
New epidemiological data on resistance to netilmicin and other aminoglycosides.
    Journal of chemotherapy (Florence, Italy), 1991, Volume: 3, Issue:6

    Topics: Amikacin; Anti-Bacterial Agents; Drug Resistance, Microbial; Enterobacteriaceae; Gentamicins; Gram-N

1991
Endotoxin filtration and immune stimulation improve survival from gram-negative sepsis.
    Surgery, 1991, Volume: 110, Issue:4

    Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adjuvants, Immunologic; Animals; Antithrombins; Benzamidines; End

1991